Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected Participants

URN to cite this document:: urn:nbn:de:bvb:355-epub-520234
DOI to cite this document:: 10.5283/epub.52023

Peterhoff, David

; Einhauser, Sebastian

; Beileke, Stephanie ; Niller, Hans-Helmut ; Günther, Felix

; Schachtner, Michael

; Asbach, Benedikt

; Steininger, Philipp ; Tenbusch, Matthias

; Peter, Antonia S.

; Gessner, Andre ; Burkhardt, Ralph

; Heid, Iris M. ; Wagner, Ralf ; Überla, Klaus

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(2MB)

Date of publication of this fulltext: 22 Apr 2022 18:21

Alternative links to fulltext:DOI Publisher Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

To assess vaccine immunogenicity in non-infected and previously infected individuals in a real-world scenario, SARS-CoV-2 antibody responses were determined during follow-up 2 (April 2021) of the population-based Tirschenreuth COVID-19 cohort study comprising 3378 inhabitants of the Tirschenreuth county aged 14 years or older. Seronegative participants vaccinated once with Vaxzevria, Comirnaty, ...